The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 23 articles
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter R,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits PC,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
Ortega-Paz L,
Brugaletta S,
Gomez-Lara J,
Alfonso F,
Cequier A,
Romaní S,
Bordes P,
Serra A,
Iñiguez A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Cuesta J,
Gómez-Hospital JA,
Sabaté M
August 5, 2022 | 10.4244/EIJ-D-21-00651
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
Rodríguez-Leor O,
Cid Alvarez A,
Perez de Prado A,
Rossello X,
Ojeda S,
Serrador A,
López-Palop R,
Martin-Moreiras J,
Rumoroso JR,
Cequier A,
Ibáñez B,
Cruz-González I,
Romaguera R,
Moreno R
April 20, 2021 | 10.4244/EIJ-D-20-00935
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J,
Ortega-Paz L,
Brugaletta S,
Cuesta J,
Romaní S,
Serra A,
Salinas P,
García del Blanco B,
Goicolea J,
Hernández-Antolín R,
Antuña P,
Romaguera R,
Regueiro A,
Rivero F,
Cequier A,
Alfonso F,
Gómez-Hospital JA,
Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial
Gomez-Lara J,
Salvatella N,
Romaguera R,
Brugaletta S,
Nato M,
Roura G,
Ferreiro J,
Teruel L,
Gracida M,
Sabaté M,
Vaquerizo B,
Cequier A,
Gomez-Hospital J
June 12, 2020 | 10.4244/EIJ-D-18-01203
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Munzel T,
Cequier A,
Buono A,
Serruys P,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y,
Onuma Y,
Asano T,
Iñiguez A,
Jensen L,
Cequier A,
Hofma S,
Christiansen E,
Suttorp M,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up
Paoletti G,
Gomez-Lara J,
Brugaletta S,
Nato M,
Romaguera R,
Roura G,
Ferreiro JL,
Teruel L,
Gracida M,
Ortega-Paz L,
Gomez-Hospital J,
Sabaté M,
Cequier A
June 20, 2018 | 10.4244/EIJ-D-17-00255
Invasive strategy and frailty in very elderly patients with acute coronary syndromes
Llao I,
Ariza-Sole A,
Sanchis J,
Alegre O,
López-Palop R,
Formiga F,
Marin F,
Vidan MT,
Martínez-Sellés M,
Sionis A,
Vives-Borras M,
Gomez-Hospital J,
Gomez-Lara J,
Roura G,
Díez-Villanueva P,
Núñez-Gil I,
Maristany J,
Asmarats L,
Bueno H,
Abu-Assi E,
Cequier A
June 14, 2018 | 10.4244/EIJ-D-18-00099
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabaté M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Onuma Y,
Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L,
Brugaletta S,
Giacchi G,
Ishida K,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Valgimigli M,
Serruys P,
Sabaté M
August 4, 2017 | 10.4244/EIJ-D-16-00512
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
Fabris E,
van 't Hof AW,
Hamm C,
Lapostolle F,
Lassen JF,
Goodman S,
ten Berg JM,
Bolognese L,
Cequier A,
Chettibi M,
Hammett C,
Huber K,
Janzon M,
Merkely B,
Storey R,
Zeymer U,
Cantor WJ,
Rousseau H,
Vicaut E,
Montalescot G
May 15, 2017 | 10.4244/EIJ-D-16-00965
IVUS-guided treatment strategies for definite late and very late stent thrombosis
Gomez-Lara J,
Salvatella N,
Gonzalo N,
Hernandez Hernandez F,
Fernández-Nofrerias E,
Sanchez Recalde A,
Bastante T,
Marcano A,
Romaguera R,
Ferreiro JL,
Roura G,
Teruel L,
Ariza-Sole A,
Miranda-Guardiola F,
Garcia-Abad V,
Gomez-Hospital J,
Alfonso F,
Cequier A
December 9, 2016 | 10.4244/EIJY15M12_08
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabaté M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
Alfonso F,
Pérez-Vizcayno M,
Cardenas A,
García del Blanco B,
García Touchard A,
Lopez-Minguez J,
Rivero F,
Masotti M,
Zueco J,
Cequier A,
Morís C,
Fernandez Ortiz A,
Escaned J,
Jiménez-Quevedo P,
Gonzalo N,
Fernandez C,
Macaya C
July 20, 2015 | 10.4244/EIJY14M09_07
Coronary perforation after bioresorbable vascular scaffold implantation
Gomez-Lara J,
Teruel L,
Romaguera R,
Roura G,
Ferreiro JL,
Sanchez-Elvira G,
Gomez-Hospital J,
Cequier A
April 20, 2015 | 10.4244/EIJV10I12A253
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023